Revance Therapeutics, Stock Forecast - Accumulation Distribution
| RVNCDelisted Stock | USD 3.65 0.00 0.00% |
Revance Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Revance Therapeutics, stock prices and determine the direction of Revance Therapeutics,'s future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Revance Therapeutics,'s historical fundamentals, such as revenue growth or operating cash flow patterns.
Revance |
| Check Revance Therapeutics, Volatility | Backtest Revance Therapeutics, | Information Ratio |
Revance Therapeutics, Trading Date Momentum
| On March 24 2025 Revance Therapeutics, was traded for 3.65 at the closing time. The top price for the day was 3.65 and the lowest listed price was 3.65 . There was no trading activity during the period 0.0. Lack of trading volume on March 24, 2025 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Revance Therapeutics, to competition
View Revance Therapeutics, Related Equities
| Risk & Return | Correlation |
Revance Therapeutics, Market Strength Events
Market strength indicators help investors to evaluate how Revance Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revance Therapeutics, shares will generate the highest return on investment. By undertsting and applying Revance Therapeutics, stock market strength indicators, traders can identify Revance Therapeutics, entry and exit signals to maximize returns.
Revance Therapeutics, Risk Indicators
The analysis of Revance Therapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Revance Therapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting revance stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.04 | |||
| Standard Deviation | 6.54 | |||
| Variance | 42.72 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Revance Stock
If you are still planning to invest in Revance Therapeutics, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Revance Therapeutics,'s history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |